Popular Pre-Market Trades in US Stocks
Newmont Corporation is up 3.00% in pre-market trading. Based on recent news,
<ol>
<li>
On January 12, Jefferies analyst Fahad Tariq maintained a Buy rating on Newmont Corporation with a target price of $120. The analyst's positive rating boosted market confidence, driving the stock price up.
</li>
<li>
On January 11, Goldman Sachs analyst Hugo Nicolaci maintained a Buy rating on Newmont Corporation with a target price of $185.10. The analyst's optimistic outlook further lifted investor sentiment, promoting a rise in the stock price.
</li>
<li>
On January 10, Newmont filed a preliminary beneficial ownership statement with the U.S. Securities and Exchange Commission, listing the holdings of two executives. This move increased market confidence in corporate governance, pushing the stock price higher. The basic materials sector has performed strongly recently, and analysts are generally optimistic.
</li>
</ol>
Top Gainers in Pre-Market Trading in US Stocks
Ping An Biomedical is up 62.15% in pre-market trading, with no significant news recently. The trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Rich Sparkle is up 38.28% in pre-market trading. Based on recent key news:
<ol>
<li>
On January 9, Rich Sparkle Holdings announced a private placement of 3 million shares at $13 per share, raising $39 million. This news drove the stock price up to a new 52-week high, reflecting market confidence in the company's financing capabilities. Source: Reuters
</li>
<li>
On January 9, the company signed an agreement to acquire all issued share capital of Step Distinctive Limited for $975 million. This significant acquisition plan is seen as an important step in the company's expansion strategy, further stimulating the rise in stock price. Source: Reuters
</li>
<li>
On January 11, Rich Sparkle Holdings completed the acquisition of the core company of TikTok influencer Khaby Lame, which is expected to significantly enhance the company's brand influence and financial performance. This move is interpreted by the market as a strategic upgrade for the company to expand its influence globally. Source: Rich Sparkle Holdings announcement. Industry expansion and acquisition activities are active, and risks need to be monitored.
</li>
</ol>
Abivax SA is up 31.76% in pre-market trading. Based on recent news,
<ol>
<li>
On January 12, French media reported that U.S. pharmaceutical giant Eli Lilly is interested in acquiring Abivax for €15 billion. This news drove Abivax's stock price up 26% in pre-market trading.
</li>
<li>
On January 12, Abivax's key drug obefazimod achieved positive results in a Phase III trial for the treatment of ulcerative colitis, making it an attractive acquisition target. This news further boosted the stock price
On January 8th, Kepler Capital analyst Justine Telliez maintained a buy rating on Abivax with a target price of €70. The analyst's optimistic expectations also support the stock price. The biotechnology sector has performed strongly recently, and investor sentiment is high
</li>
</ol>

Newmont Mining pre-market up 3.00%; Ping An Biomedical pre-market up 62.15%; Rich Sparkle pre-market up 38.28%; Abivax SA pre-market up 31.76%

Hot pre-market trades in US stocks: Analysts are optimistic, Newmont Mining rises 3% in pre-market